Advisers urge more tests of diabetes drugs
SILVER SPRING, Maryland (Reuters) - U.S. regulators should require more testing of the potential heart risks of new diabetes medicines, an advisory panel said on Wednesday.
More: continued here
Leave a Reply
You must be logged in to post a comment.